Retatrutide promises big weight loss, but safety remains a question
Liraglutide is currently under investigation for its potential effects on obesity-related conditions such as polycystic ovary syndrome (PCOS), non-alcoholic fatty liver disease (NAFLD), and others
11 Because visceral fat and insulin resistance reinforce each other, reducing one helps interrupt the other, ultimately lowering the disease process that increases cardiovascular risk
The medication may be taken long-term, provided it remains effective and is well tolerated
Customer Reviews: What Real Users Say What people praise: Many users report a great customer experience
Of these, 1,465 patients were taking semaglutide and tirzepatide higher-dose jabs recommended specifically for weight loss